logo
Log inSign up
logo

AstraZeneca R&D Center

Sector: Commercial • Location: Beijing, China

Source: Site Selection Magazine

Project
Planned

AstraZeneca plans to establish a second global strategic R&D center in Beijing, marking its sixth global R&D center investment. This $2.5 billion investment aims to enhance collaboration and access to talent in the life sciences ecosystem in Beijing.

Status
Prospective
Sector
Commercial
Location
Beijing, China
Updated
22 Jul 2026
Source
Site Selection Magazine

ConstructChat

Ask ConstructChat about AstraZeneca R&D Center

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “AstraZeneca R&D Center” is an infrastructure initiative in the Commercial sector, located in Beijing, China. Taiyo aggregates data on it from Site Selection Magazine.

Participants

Not available for this record.

Status

Original status

Planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

AstraZeneca plans to establish a second global strategic R&D center in Beijing, marking its sixth global R&D center investment. This $2.5 billion investment aims to enhance collaboration and access to talent in the life sciences ecosystem in Beijing.

Budget

Location

Country

China

City

Beijing

Source

Source

Site Selection Magazine

URL

More Details

Record type

Project

Sector

Commercial

Article published date

2025-04-20

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project